Although both Sirt3 and PPAR-γ are considered as attractive targets for therapies against stroke and other neurological disorders [7, 8], the full detailed correlation between Sirt3 and PPAR-γ in brain I/R and stroke is still not clear. The gene discussed is PPARG; the disease is stroke disorder.